Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
22,498,451
-
Share change
-
+4,749,926
-
Total reported value
-
$535,583,972
-
Put/Call ratio
-
139%
-
Price per share
-
$23.81
-
Number of holders
-
120
-
Value change
-
+$123,430,026
-
Number of buys
-
74
-
Number of sells
-
41
Institutional Holders of ENDOCYTE INC - COM (ECYT) as of Q1 2014
As of 31 Mar 2014,
ENDOCYTE INC - COM (ECYT) was held by
120 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,498,451 shares.
The largest 10 holders included
FMR LLC, BB BIOTECH AG, BlackRock Fund Advisors, PINNACLE ASSOCIATES LTD, VANGUARD GROUP INC, ORACLE INVESTMENT MANAGEMENT INC, ADAGE CAPITAL PARTNERS GP LLC, State Street Corp, AQR CAPITAL MANAGEMENT LLC, and RS INVESTMENT MANAGEMENT CO LLC.
This page lists
120
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.